期刊论文详细信息
Journal of Biological Engineering
Delivery systems of CRISPR/Cas9-based cancer gene therapy
Francesca Margheri1  Anna Laurenzana1  Alessio Biagioni1  Anastasia Chillà1  Mario Del Rosso1  Gabriella Fibbi1 
[1] Department of Experimental and Clinical Biomedical Sciences, University of Florence;
关键词: CRISPR;    Delivery systems;    Gene-editing;    Cancer;    Gene therapy;   
DOI  :  10.1186/s13036-018-0127-2
来源: DOAJ
【 摘 要 】

Abstract CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) is today one of the most reliable method for gene-editing, supporting previous gene therapies technologies such as TALEN, Meganucleases and ZFNs. There is a growing up number of manuscripts reporting several successful gene-edited cancer cell lines, but the real challenge is to translate this technique to the clinical practice. While treatments for diseases based on a single gene mutation is closer, being possible to target and repair the mutant allele in a selective way generating specific guide RNAs (gRNAs), many steps need to be done to apply CRISPR to face cancer. In this review, we want to give a general overview to the recent advancements in the delivery systems of the CRISPR/Cas9 machinery in cancer therapy.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次